<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05030961</url>
  </required_header>
  <id_info>
    <org_study_id>20210584</org_study_id>
    <nct_id>NCT05030961</nct_id>
  </id_info>
  <brief_title>Team-based Virtual Pediatric Cochlear Implant Clinic</brief_title>
  <official_title>Implementation of a Team-based Virtual Clinic for Pediatric Cochlear Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanley J. Glaser Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if remote visits for pediatric cochlear implant patients&#xD;
      are possible. The investigator will be assessing whether a multi-disciplinary team approach&#xD;
      can be achieved remotely for patients both undergoing the cochlear implant (CI) process and&#xD;
      for those who have already been implanted.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Electrode Impedances</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Electrode Impedances values, reported in kOhm, will be extracted from the cochlear implant software</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Electrically evoked compound potential values</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Electrically evoked compound potential values, reported in mV, will be extracted from the cochlear implant software</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Datalogging</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Datalogging, reported in hours per week, will be extracted from the cochlear implant software</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Threshold/Upper stimulation levels</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>As measured from the cochlear implant software</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LittleEars questionnaire scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>The LittleEars auditory questionnaire (LEAQ) uses parent responses to assess auditory behavior in children up to 24 months of age. The questionnaire is scored from 0 to 35 with 0 indicating poorer performance and 35 indicating better performance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Auditory Skills Checklist (ASC) scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>ASC has a Total Score ranges from zero to 70, with higher scores indicating development of increasingly complex listening skills</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Behavior Assessment System for Children version 3 (BASC-3) scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>BASC-3 is scored 0-120 as a T score. Any scores between 60-70 is considered at risk / requires monitoring and scores greater than 70 are considered clinically significant / an area that likely requires therapeutic intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire version 8 (PHQ-8) scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>PHQ-8 has 8 items rated on a scale from &quot;not at all&quot; (0) to &quot;nearly every day&quot; (3), with higher scores indicating greater frequency of depressive symptoms. The sum of the items indicates the overall level of depressive symptoms indicating mild (5-9), moderate (10-14), moderately severe (15-19), and severe depressive symptoms (20- 24).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder version 7 (GAD-7) scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>GAD-7 is a 7-item self-report questionnaire of anxiety symptomatology in the past 14 days. Respondents rate the frequency of each item during the past two weeks on a 0-3-point scale ranging from not at all (0) to nearly every day (3). The sum of the items indicates the overall level of anxiety symptoms indicating mild (0-4), moderate (5-9), moderately severe (10-14), and severe (15- 21).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life- CI (QoL-CI) scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>QoL-CI is scored 0-100 with higher scores indicating better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cochlear Implant Quality of Life-35 Profile (CIQOL-35 Profile) scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>CIQOL-35 Profile is a 35 item questionnaire with a total score ranging from 0-100% with a higher score indicating a higher level of functional ability with a cochlear implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parenting Stress Index/Short Form (PSI) scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Parenting Stress Index/Short Form (PSI) contains 36 items rated on a 6-point Likert scale (1 = Strongly Disagree to 5 = Strongly Agree) and a total score. Higher scores indicate increased parenting stress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parenting Stress-CI scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Parenting Stress-CI is completed by the parent and scored from &quot;not at all stressful&quot; (0) to &quot;very stressful&quot; (3) with higher scores indicating greater degrees of parenting stress. For parents of children 0-5 years, there are 15 items. For parents of children 6-12 years there are 8 items.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scale of Parental Involvement and Self-Efficacy-Revised (SPISE-R) scores</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>The SPISE-R is comprised of 46 questions that uses a 7-point Likert scale to query parents' beliefs, knowledge, confidence, and actions relevant to supporting their child's auditory access and spoken language development. The total average score will range from 1 to 7 with 7 indicating the highest score / highest level of parental involvement and self efficacy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Pediatric Cochlear Implant Candidate Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who are in the process of receiving standard of care cochlear implant evaluation. Participants will receive a virtual team-based clinic as a part of the candidacy evaluation process for one year.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Established Cochlear Implant Recipient Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who are established cochlear implant recipients. Participants will receive a virtual team-based clinic, including remote cochlear implant programming, for one year.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Virtual team-based clinic</intervention_name>
    <description>Virtual team-based clinic will include consultation, counseling, and education from pediatric audiology, psychology, auditory verbal therapy, and education. Each session lasts approximately 30 minutes with a total of 3 sessions within the year.</description>
    <arm_group_label>Established Cochlear Implant Recipient Group</arm_group_label>
    <arm_group_label>Pediatric Cochlear Implant Candidate Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Remote cochlear implant programming</intervention_name>
    <description>Remote cochlear implant programming will be provided via Zoom on a study-provided encrypted laptop.</description>
    <arm_group_label>Established Cochlear Implant Recipient Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        New patients undergoing CI evaluation:&#xD;
&#xD;
          1. English speaking patients (parents can speak English and/or Spanish)&#xD;
&#xD;
          2. Ages 0-12 years who are cochlear implant candidates and undergoing the evaluation&#xD;
             process&#xD;
&#xD;
        Established CI recipients:&#xD;
&#xD;
          1. English speaking patients (parents can speak English and/or Spanish)&#xD;
&#xD;
          2. Ages 1-12 with at least 6 months of CI experience with a company that has remote&#xD;
             programming capacity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with families who speak languages other than English or Spanish&#xD;
&#xD;
          2. Patients who do not live in Florida&#xD;
&#xD;
          3. Patients who have any condition that, in the opinion of the investigator, would&#xD;
             compromise the well-being of the patient or the study or prevent the patient from&#xD;
             meeting or performing study requirements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chrisanda M Sanchez, AuD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina Sarangoulis</last_name>
    <phone>305-243-8397</phone>
    <email>cmd247@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Sarangoulis</last_name>
      <phone>305-234-8397</phone>
      <email>cmd247@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Chrisanda M Sanchez, AuD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Chrisanda Sanchez</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

